101
|
Buskulic D, Decamp D, Goy C, Lees JP, Minard MN, Mours B, Alemany R, Ariztizabal F, Comas P, Crespo JM, Delfino M, Fernandez E, Gaitan V, Garrido L, Mir LM, Pacheco A, Pascual A, Creanza D, Plama M, Farilla A, Iaselli G, Maggi G, Maggi M, Natali S, Nuzzo S, Quattromini M, Ranieri A, Raso G, Romano F, Ruggieri F, Selvaggi G, Silvestris L, Tempesta P, Zito G, Gao Y, Hu H, Huang D, Huang X, Lin J, Lou J, Qiao C, Wang T, Xie Y, Xu D, Xu R, Zhang J, Zhao W, Atwood WB, Bauerdick LAT, Blucher E, Bonvicini G, Bossi F, Boudreau J, Burnett TH, Drevermann H, Forty RW, Hagelberg R, Harvey J, Haywood S, Hilgart J, Jacobsen R, Jost B, Knobloch J, Lan�on E, Lehraus I, Lohse T, Lusiani A, Martinez M, Mato P, Mattison T, Meinhard H, Menary S, Meyer T, Minten A, Miotto A, Miquel R, Moser HG, Nash J, Palazzi P, Perlas JA, Ranjard G, Redlinger G, Rolandi L, Roth A, Rothberg J, Ruan T, Saich M, Schlatter D, Schmelling M, Sefkow F, Tejessy W, Wachsmuth H, Wiedenmann W, Wildish T, Witzeling W, Wotschak J, Ajaltouni Z, Badaud F, Bardadin-Otwinowska M, Bencheikh AM, Fellous R, Falvard A, Gay P, Guicheney C, Henrard P, Jousset J, Michel B, Montret JC, Pallin D, Perret P, Pietrzyk B, Proriol J, Preulhi�re F, Stimpfl G, Fearnley T, Hansen JD, Hansen JR, Hansen PH, M�llerud R, Nilsson BS, Efthymiopoulos I, Kyriakis A, simopoulou E, Vayaki A, Zachariadou K, Badier J, Blondel A, Bonneaud G, Brient JC, Fouque G, Gamess A, Orteu S, Rosowsky A, Roug� A, Rumpf M, Tanaka R, Videau H, Candlin DJ, Parsons MI, Veitch E, Moneta L, Parrini G, Corden M, Georgiopoulos C, Ikeda M, Lannutti J, Levinthal D, Mermikides M, Sawyer L, Wasserbaech S, Antonelli A, Baldini R, Bencivenni G, Bologna G, Campana P, Capon G, Cerutti F, Chiarella V, D'Ettorre-Piazzoli B, Felici G, Laurelli G, Mannocchi G, Murtas F, Murtas GP, Passalacqua L, Pepe-Altarelli M, Picchi P, Altoon B, Boyle O, Colrain P, Have I, Lynch JG, Maitland W, Morton WT, Raine C, Scarr JM, Smith K, Thompson AS, Turnbull RM, Brandl B, Braun O, Geiges R, Geweniger C, Hanke P, Hepp V, Kluge EE, Maumary Y, Putzer A, Rensch B, Stahl A, Tittel K, Wunsch M, Belk AT, Beuselinck R, Binnie DM, Cameron W, Cattaneo M, Colling DJ, Dornan PJ, Dugeay S, Greene AM, Hassard JF, Lieske NM, Patton SJ, Payne DG, Phillips MJ, Sedgbeer JK, Tomalin IR, Wright AG, Kneringer E, Kuhn D, Rudolph G, Bowdery CK, Brodbeck TJ, Finch AJ, Foster F, Hughes G, Jackson D, Keemer NR, Nuttall M, Patel A, Sloan T, Snow SW, Whelan EP, Barczewski T, Kleinknecht K, Raab J, Renk B, Roehn S, Sander HG, Schmidt H, Steeg F, Walther SM, Wolf B, Aubert JJ, Benchouk C, Bernard V, Bonissent A, Carr J, Coyle P, Drinkard J, Etienne F, Papalexiou S, Payre P, Qian Z, Rousseau D, Schwemling P, Talby M, Adlung S, Becker H, Blum W, Brown D, Cattaneo P, Cowan G, Dehning B, Dietl H, Dydak F, Fernandez-Bosman M, Frank M, Halley AW, Hansl-Kozanecka T, Lauber J, L�tjens G, Lutz G, M�nner W, Pan Y, Richter R, Rotscheidt H, Schr�der J, Schwarz AS, Settles R, Stierlin U, Stiegler U, Denis RS, Takashima M, Thomas J, Wolf G, Bertin V, Boucrot J, Callot O, Chen X, Cordier A, Davier M, Grivaz JF, Heusse P, Janot P, Kim DW, Diberder F, Lefran�ois J, Lutz AM, Schune MH, Veillet JJ, Videau I, Zhang Z, Zomer F, Abbaneo D, Amendolia SR, Bagliesi G, Batignani G, Bosisio L, Bottigli U, Bradaschia C, Carpinelli M, Ciocci MA, Dell'Orso R, Ferrante I, Fidecaro F, Fo� L, Focardi E, Forti F, Giassi A, Giorgi MA, Ligabue F, Mannelli EB, Marrocchesi PS, Messineo A, Palla F, Rizzo G, Sanguinetti G, Steinberger J, Technini R, Tonelli G, Triggiani G, Vannini C, Venturi A, Verdini PG, Walsh J, Carter JM, Green MG, March PV, Medcalf T, Quazi IS, Strong JA, West LR, Botterill DR, Clifft RW, Edgecock TR, Edwards M, Fisher SM, Jones TJ, Norton PR, Salmon DP, Thompson JC, Bloch-Devaux B, Colas P, Kozanecki W, Lemaire MC, Locci E, Loucatos S, Monnier E, Perez P, Perrier F, Rander J, Renardy JF, Roussarie A, Schuller JP, Schwindling J, Mohand D, Vallage B, Johnson RP, Litke AM, Taylor G, Wear J, Ashman JG, Babbage W, Booth CN, Buttar C, Carney RE, Cartwright S, Combley F, Hatfield F, Reeves P, Thompson LF, Barberio E, Brandt S, Grupen C, Mirabito L, Sch�fer U, Seywerd H, Ganis G, Giannini G, Gobbo B, Ragusa F, Bellantoni L, Cinabro D, Conway JS, Cowen DF, Feng Z, Ferguson DPS, Grahl J, Harton JL, Jared RC, LeClaire BW, Lishka C, Pater JR, Saadi Y, Sharma V, Schmitt M, Shi ZH, Tang YH, Walsh AM, Weber FV, Whitney MH, Wu SL, Wu X, Zobernig G. Properties of hadronicZ decays and test of QCD generators. ACTA ACUST UNITED AC 1992. [DOI: 10.1007/bf01482583] [Citation(s) in RCA: 56] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
|
33 |
56 |
102
|
Zhao W, Rafailovich MH, Sokolov J, Fetters LJ, Plano R, Sanyal MK, Sinha SK, Sauer BB. Wetting properties of thin liquid polyethylene propylene films. PHYSICAL REVIEW LETTERS 1993; 70:1453-1456. [PMID: 10053296 DOI: 10.1103/physrevlett.70.1453] [Citation(s) in RCA: 56] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
|
|
32 |
56 |
103
|
Guo P, Ma X, Zhao W, Huai W, Li T, Qiu Y, Zhang Y, Han L. TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1–TSC2 complex. Oncogene 2017; 37:478-488. [DOI: 10.1038/onc.2017.349] [Citation(s) in RCA: 56] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2016] [Revised: 08/16/2017] [Accepted: 08/21/2017] [Indexed: 12/20/2022]
|
|
8 |
56 |
104
|
Urfer R, Tsoulfas P, O'Connell L, Hongo JA, Zhao W, Presta LG. High resolution mapping of the binding site of TrkA for nerve growth factor and TrkC for neurotrophin-3 on the second immunoglobulin-like domain of the Trk receptors. J Biol Chem 1998; 273:5829-40. [PMID: 9488719 DOI: 10.1074/jbc.273.10.5829] [Citation(s) in RCA: 55] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023] Open
Abstract
Neurotrophic factors are important for survival and maintenance of neurons during developmental and adult stages of the vertebrate nervous system. The neurotrophins mediate their signal into the cell by specific interaction with tyrosine kinase receptors of the Trk family. The extracellular immunoglobulin-like domain of the Trk receptors adjacent to the membrane has previously been shown to be the dominant element for specific neurotrophin binding. Using computer graphics models of the human TrkA and TrkC immunoglobulin-like domains as a guide, the residues involved in binding to their respective neurotrophins were mapped by mutational analysis. TrkC primarily utilizes loop EF, between beta-strands E and F, for binding. In contrast, TrkA utilizes the EF loop as well as additional residues, the latter being prime candidates for determining the specificity of TrkA versus TrkC. When selected TrkC and TrkA mutants with reduced binding were expressed on NIH3T3 cells, neurotrophin-induced autophosphorylation was strongly reduced or absent.
Collapse
MESH Headings
- Amine Oxidase (Copper-Containing)
- Amino Acid Sequence
- Animals
- Antibodies, Monoclonal/immunology
- Antibodies, Monoclonal/metabolism
- Binding Sites/physiology
- Cell Adhesion Molecules/chemistry
- Cell Line
- Epitope Mapping
- Gene Expression/genetics
- Mice
- Models, Molecular
- Molecular Sequence Data
- Mutagenesis, Site-Directed/genetics
- Nerve Growth Factors/metabolism
- Neurotrophin 3
- Phosphorylation
- Protein Structure, Secondary
- Proto-Oncogene Proteins/chemistry
- Proto-Oncogene Proteins/genetics
- Proto-Oncogene Proteins/metabolism
- Receptor Protein-Tyrosine Kinases/chemistry
- Receptor Protein-Tyrosine Kinases/genetics
- Receptor Protein-Tyrosine Kinases/metabolism
- Receptor, trkA
- Receptor, trkC
- Receptors, Nerve Growth Factor/chemistry
- Receptors, Nerve Growth Factor/genetics
- Receptors, Nerve Growth Factor/metabolism
- Sequence Alignment
Collapse
|
|
27 |
55 |
105
|
Corbett JA, Wang JL, Misko TP, Zhao W, Hickey WF, McDaniel ML. Nitric oxide mediates IL-1 beta-induced islet dysfunction and destruction: prevention by dexamethasone. Autoimmunity 1993; 15:145-53. [PMID: 7692996 DOI: 10.3109/08916939309043889] [Citation(s) in RCA: 55] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
Nitric oxide has recently been implicated as a cellular molecule that mediates interleukin-1 beta (IL-1 beta)-induced inhibition of glucose-stimulated insulin secretion by islets of Langerhans. In this study evidence is presented which demonstrates that islets contain both the cytokine inducible and the constitutive isoforms of nitric oxide synthase as determined by NADPH diaphorase staining and immunohistochemical localization. Untreated islets contain NADPH diaphorase activity, and the intensity of NADPH diaphorase staining is dramatically increased after culture for 18 hrs with IL-1 beta. Both control and IL-1 beta-induced NADPH diaphorase staining of islets is inhibited by the nitric oxide synthase inhibitor NG-monomethyl-L-arginine (NMMA). Importantly, approximately 60-70% of islet cells stained positive for NADPH diaphorase (under both IL-1 beta treated and control conditions), suggesting that a subset of islet cells contain nitric oxide synthase. The beta-cell appears to be the endocrine cell type which contains constitutive nitric oxide synthase as demonstrated by immunohistochemical co-localization of constitutive nitric oxide synthase and insulin. IL-1 beta is believed to stimulate the expression of cytokine inducible nitric oxide synthase because the synthetic glucocorticoid, dexamethasone, prevents IL-1 beta induced inhibition of glucose stimulated insulin secretion and cGMP accumulation by islets. Both dexamethasone, and the nitric oxide synthase inhibitors NMMA and aminoguanidine also prevent IL-1 beta induced islet degeneration. These results indicate that nitric oxide produced by the inducible isoform of nitric oxide synthase mediates cytokine induced islet dysfunction and destruction, and that the beta-cell is the islet endocrine cellular source of constitutive nitric oxide synthase.
Collapse
|
|
32 |
55 |
106
|
Wang Q, Sun B, Wang D, Ji Y, Kong Q, Wang G, Wang J, Zhao W, Jin L, Li H. Murine bone marrow mesenchymal stem cells cause mature dendritic cells to promote T-cell tolerance. Scand J Immunol 2008; 68:607-15. [PMID: 18959624 DOI: 10.1111/j.1365-3083.2008.02180.x] [Citation(s) in RCA: 55] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Bone mesenchymal stem cells (BMSC) are attractive not only in regenerative medicine, but also for the treatment of autoimmune diseases and graft-versus-host disease. BMSC also play a role in enabling alloantigen tolerance. An in-depth mechanistic understanding of this phenomenon of tolerance could lead to novel cell-based therapies for autoimmune disease. We demonstrate here that co-culture of mature dendritic cells (DC) with BMSC in a transwell system (BMSC-DC) downregulated expression of the maturation marker, CD83 and CD80/86 co-stimulatory molecules on DC, while increasing their endocytic activity. This resulted in defective antigen presentation and co-stimulatory capacity of mature DC. Functionally, BMSC-DC have impaired T-cell stimulatory activity in a mixed lymphocyte reaction and orchestrate a shift from predominantly pro-inflammatory T-helper (Th)-1 to anti-inflammatory Th2 cells. While the expression of MHC II, CD80 and CD86 were upregulated on BMSC co-cultured with DC, these BMSC lacked the ability to stimulate T-cell proliferation. Taken together, these data suggest that the interaction between BMSC and DC modulates the immunoregulatory function of these cells in a coordinated manner, effectively skewing the immune response towards T-cell tolerance.
Collapse
|
|
17 |
55 |
107
|
Lok K, Zhao H, Shen H, Wang Z, Gao X, Zhao W, Yin M. Characterization of the APP/PS1 mouse model of Alzheimer's disease in senescence accelerated background. Neurosci Lett 2013; 557 Pt B:84-9. [PMID: 24176881 DOI: 10.1016/j.neulet.2013.10.051] [Citation(s) in RCA: 55] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2013] [Revised: 10/10/2013] [Accepted: 10/18/2013] [Indexed: 11/26/2022]
Abstract
The APP/PS1 mouse model of Alzheimer's disease (AD) exhibits remarkable elevation of β-amyloid production associated with certain behavioral abnormalities, while the senescence accelerated mouse prone 8 (SAMP8) is characterized by early and age-related deterioration of learning and memory. In order to obtain an AD model that develops earlier pathological changes and cognitive impairment, we generated SAMP8-APP/PS1, a novel senescence accelerated APP/PS1 transgenic mouse model of AD. Standard histological staining and immunohistochemistry using an amyloid beta (Aβ) antibody showed an age, genotype and strain-dependent progression of amyloid deposition and neuron loss in the cerebral cortex and hippocampus of SAMP8-APP/PS1 mice. Results from the cognitive behavioral tests revealed early deficits in learning and memory in SAMP8-APP/PS1 mice in the two way active avoidance and Morris water maze tests compared with C57-APP/PS1, SAMP8 wild-type and control mice. These results suggest that accelerated senescence exacerbates amyloid deposition and cognitive dysfunction in APP/PS1 mice and the senescence accelerated-APP/PS1 (SAMP8-APP/PS1) mouse model might be a valuable tool to study AD progression and to evaluate the effect of drugs on AD.
Collapse
|
Research Support, Non-U.S. Gov't |
12 |
55 |
108
|
Pan T, Zhong L, Wu S, Cao Y, Yang Q, Cai Z, Cai X, Zhao W, Ma N, Zhang W, Zhang H, Zhou J. 17β-Oestradiol enhances the expansion and activation of myeloid-derived suppressor cells via signal transducer and activator of transcription (STAT)-3 signalling in human pregnancy. Clin Exp Immunol 2016; 185:86-97. [PMID: 26969967 DOI: 10.1111/cei.12790] [Citation(s) in RCA: 54] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/08/2016] [Indexed: 12/12/2022] Open
Abstract
During a successful pregnancy, the maternal immune system plays a critical role in maintaining immunotolerance towards semi-allogeneic fetal antigens. Recent studies have indicated that myeloid-derived suppressor cells (MDSCs) are active players in establishing fetal-maternal tolerance; however, the underlying mechanism remains poorly understood. In this study, we observed a significant expansion of monocytic MDSCs (M-MDSCs) in the peripheral blood of pregnant women, which suppressed T cell responses in a reactive oxygen species-dependent manner and required cell-cell contact. The number of M-MDSCs correlated positively with serum oestrogen and progesterone levels. Administration of 17β-oestradiol, but not progesterone, enhanced both the expansion and suppressive activity of M-MDSCs through signal transducer and activator of transcription (STAT)-3. Pretreatment with STAT-3 inhibitor JSI-124 almost completely abrogated the effects of 17β-oestradiol on MDSCs. Collectively, these results demonstrate that 17β-oestradiol-induced STAT-3 signalling plays an important role in both the expansion and activation of MDSCs during human pregnancy, which may benefit the development of novel therapeutic strategies for prevention of immune-related miscarriage.
Collapse
|
Research Support, Non-U.S. Gov't |
9 |
54 |
109
|
Nadler R, Luo Y, Zhao W, Ritchey JK, Austin JC, Cohen MB, O'Donnell MA, Ratliff TL. Interleukin 10 induced augmentation of delayed-type hypersensitivity (DTH) enhances Mycobacterium bovis bacillus Calmette-Guérin (BCG) mediated antitumour activity. Clin Exp Immunol 2003; 131:206-16. [PMID: 12562379 PMCID: PMC1808633 DOI: 10.1046/j.1365-2249.2003.02071.x] [Citation(s) in RCA: 54] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Intravesical BCG therapy is effective in the treatment of superficial bladder cancer. Both clinical and experimental results suggest a role for cytokines and delayed-type hypersensitivity (DTH) in BCG-induced antitumour immunity. We characterized the modulatory effects of BCG on bladder cytokine expression and determined the relationship between DTH and BCG antitumour activity. The bladders of mice were instilled with BCG through a catheter. Bladder tissue RNA and urine were collected for evaluation of cytokine expression using reverse transcriptase-polymerase chain reaction (RT-PCR) and/or ELISA. IFN-gamma and TNF-alpha, the two major cytokines associated with DTH, were efficiently induced by BCG. IL10, an important down-regulator of DTH, was also induced by BCG. Constitutive levels of IL4 and IL5 were observed, but neither IL4 nor IL5 were modulated by BCG. Similar results were observed in the kinetic analysis of urinary cytokines in patients after intravesical BCG therapy. Production of Th1 (T helper type 1) cytokines (IFN-gamma, IL2 and IL12) preceded that of the Th2 (T helper type 2) cytokine IL10. A tendency toward higher ratios of IFN-gamma versus IL10 for BCG responders also was observed. In animal studies the absence of IL10 abrogated either by antibody inhibition or the use of genetically modified, IL10 deficient (IL10-/-) mice resulted in enhanced DTH responses. Under conditions of enhanced DTH, a significant enhancement in antitumour activity was observed. These data demonstrate that DTH and its associated mononuclear infiltration and cytokine production are important to the antitumour activity of intravesical BCG therapy, and suggest that effects to diminish IL10 production may have therapeutic value.
Collapse
|
research-article |
22 |
54 |
110
|
Jones D, Woyach JA, Zhao W, Caruthers S, Tu H, Coleman J, Byrd JC, Johnson AJ, Lozanski G. PLCG2 C2 domain mutations co-occur with BTK and PLCG2 resistance mutations in chronic lymphocytic leukemia undergoing ibrutinib treatment. Leukemia 2017; 31:1645-1647. [PMID: 28366935 DOI: 10.1038/leu.2017.110] [Citation(s) in RCA: 53] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|
Journal Article |
8 |
53 |
111
|
Christiansen C, Castillo-Fernandez JE, Domingo-Relloso A, Zhao W, El-Sayed Moustafa JS, Tsai PC, Maddock J, Haack K, Cole SA, Kardia SLR, Molokhia M, Suderman M, Power C, Relton C, Wong A, Kuh D, Goodman A, Small KS, Smith JA, Tellez-Plaza M, Navas-Acien A, Ploubidis GB, Hardy R, Bell JT. Novel DNA methylation signatures of tobacco smoking with trans-ethnic effects. Clin Epigenetics 2021; 13:36. [PMID: 33593402 PMCID: PMC7888173 DOI: 10.1186/s13148-021-01018-4] [Citation(s) in RCA: 53] [Impact Index Per Article: 13.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2020] [Accepted: 01/24/2021] [Indexed: 12/13/2022] Open
Abstract
BACKGROUND Smoking remains one of the leading preventable causes of death. Smoking leaves a strong signature on the blood methylome as shown in multiple studies using the Infinium HumanMethylation450 BeadChip. Here, we explore novel blood methylation smoking signals on the Illumina MethylationEPIC BeadChip (EPIC) array, which also targets novel CpG-sites in enhancers. METHOD A smoking-methylation meta-analysis was carried out using EPIC DNA methylation profiles in 1407 blood samples from four UK population-based cohorts, including the MRC National Survey for Health and Development (NSHD) or 1946 British birth cohort, the National Child Development Study (NCDS) or 1958 birth cohort, the 1970 British Cohort Study (BCS70), and the TwinsUK cohort (TwinsUK). The overall discovery sample included 269 current, 497 former, and 643 never smokers. Replication was pursued in 3425 trans-ethnic samples, including 2325 American Indian individuals participating in the Strong Heart Study (SHS) in 1989-1991 and 1100 African-American participants in the Genetic Epidemiology Network of Arteriopathy Study (GENOA). RESULTS Altogether 952 CpG-sites in 500 genes were differentially methylated between smokers and never smokers after Bonferroni correction. There were 526 novel smoking-associated CpG-sites only profiled by the EPIC array, of which 486 (92%) replicated in a meta-analysis of the American Indian and African-American samples. Novel CpG sites mapped both to genes containing previously identified smoking-methylation signals and to 80 novel genes not previously linked to smoking, with the strongest novel signal in SLAMF7. Comparison of former versus never smokers identified that 37 of these sites were persistently differentially methylated after cessation, where 16 represented novel signals only profiled by the EPIC array. We observed a depletion of smoking-associated signals in CpG islands and an enrichment in enhancer regions, consistent with previous results. CONCLUSION This study identified novel smoking-associated signals as possible biomarkers of exposure to smoking and may help improve our understanding of smoking-related disease risk.
Collapse
|
Meta-Analysis |
4 |
53 |
112
|
Williams GW, Hubbard RC, Yu SS, Zhao W, Geis GS. Comparison of once-daily and twice-daily administration of celecoxib for the treatment of osteoarthritis of the knee. Clin Ther 2001; 23:213-27. [PMID: 11293555 DOI: 10.1016/s0149-2918(01)80004-7] [Citation(s) in RCA: 52] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
OBJECTIVE The purpose of this study was to compare the efficacy and tolerability of a celecoxib 200 mg QD regimen with a 100 mg BID regimen in patients with osteoarthritis (OA) of the knee. METHODS Patients enrolled in this prospective, double-blind, placebo-controlled, parallel-group, multicenter study were randomly assigned to receive celecoxib 100 mg BID, celecoxib 200 mg QD, or placebo for 6 weeks. Assessments of OA severity (Patient's and Physician's Global Assessments of Arthritis, Patient's Assessment of Arthritis Pain-Visual Analog Scale, Lequesne Osteoarthritis Severity Index, and the Western Ontario and McMaster Universities Osteoarthritis Index) were performed at baseline and at week 2 and/or 6. Patients who discontinued treatment underwent assessments at the time of withdrawal from the study. RESULTS Of the 718 patients enrolled, 243 received celecoxib 100 mg BID, 231 received celecoxib 200 mg QD, and 244 received placebo. For all measures of efficacy, at all assessments, improvements from baseline in both celecoxib groups were superior to that seen in the placebo group (P < 0.05). No significant differences in efficacy between the celecoxib groups were observed. The overall incidence of adverse events was similar in the 2 celecoxib treatment groups. CONCLUSIONS Dosing regimens of celecoxib 200 mg QD and 100 mg BID are equally effective and well tolerated in patients with OA of the knee. The availability of 2 effective regimens provides patients and physicians with increased flexibility in the selection of an appropriate dosing regimen for celecoxib therapy.
Collapse
|
Clinical Trial |
24 |
52 |
113
|
Vigneswaran N, Zhao W, Dassanayake A, Muller S, Miller DM, Zacharias W. Variable expression of cathepsin B and D correlates with highly invasive and metastatic phenotype of oral cancer. Hum Pathol 2000; 31:931-7. [PMID: 10987253 DOI: 10.1053/hupa.2000.9035] [Citation(s) in RCA: 51] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
The expression levels of cathepsins B, D, and L in oral cancer surgical specimens were determined using immunocytochemical analysis. Cathepsins B and D are frequently overexpressed in squamous cell carcinomas, whereas their overexpression was less frequent in verrucous carcinoma and basaloid squamous cell carcinomas. Elevated level of cathepsin B in oral carcinomas was significantly associated with advanced tumor stage (P < .05) and poor histologic malignancy grade (P < .001). Increased expression of cathepsin D correlated significantly with the presence of metastasis (P < .05), poor histologic malignancy grade (P < .001), and high proliferation rate (P < .05). Cathepsin L was less frequently overexpressed in oral cancers than cathepsin B and D. These findings indicate that there is a strong cause/effect relationship between the expression levels of cathepsin B and D in oral cancers and their local invasive and metastatic growth patterns. Thus, cathepsins B and D are useful prognostic markers as well as promising gene therapy targets for oral cancer.
Collapse
|
|
25 |
51 |
114
|
Zhao W, Ji WG, Rowlands JA. Effects of characteristic x rays on the noise power spectra and detective quantum efficiency of photoconductive x-ray detectors. Med Phys 2001; 28:2039-49. [PMID: 11695766 DOI: 10.1118/1.1405845] [Citation(s) in RCA: 51] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
The effects of K fluorescence on the imaging performance of photoconductor-based x-ray imaging systems are investigated. A cascaded linear systems model was developed, where a parallel cascaded process was implemented to take into account the effect of K-fluorescence reabsorption on the modulation transfer function (MTF), noise power spectrum (NPS), and the spatial frequency dependent detective quantum efficiency [DQE(f)] of an imaging system. The investigation was focused on amorphous selenium (a-Se), which is the most highly developed photoconductor material for x-ray imaging. The results were compared to those obtained with Monte Carlo simulation using the same imaging condition and detector parameters, so that the validity of the cascaded linear system model could be confirmed. Our results revealed that K-fluorescence reabsorption in a-Se is responsible for a 18% drop in NPS at high spatial frequencies with an incident x-ray photon energy of E=20 keV (which is just above the K edge of 12.5 keV). When E increases to 60 keV, the effects of K-fluorescence reabsorption on NPS decrease to approximately 12% at high spatial frequencies. Because the high frequency drop is present in both MTF and NPS, the effect of K fluorescence on DQE(f) is minimal, especially for E that is much higher than the K edge. We also applied the cascaded linear system model to a newly developed compound photoconductor, lead iodide (PbI2), and found that at 60 keV there is a high frequency drop in NPS of 19%. The calculated NPS were compared to previously published measurements of PbI2 detectors.
Collapse
|
|
24 |
51 |
115
|
Zhao W, Young TY, Ginsberg MD. Registration and three-dimensional reconstruction of autoradiographic images by the disparity analysis method. IEEE TRANSACTIONS ON MEDICAL IMAGING 1993; 12:782-791. [PMID: 18218474 DOI: 10.1109/42.251130] [Citation(s) in RCA: 51] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
Quantitative autoradiography is a powerful radioisotopic-imaging method for neuroscientists to study local cerebral blood flow and glucose-metabolic rate at rest, in response to physiologic activation of the visual, auditory, somatosensory, and motor systems, and in pathologic conditions. Most autoradiographic studies analyze glucose utilization and blood flow in two-dimensional (2D) coronal sections. With modern digital computer and image-processing techniques, a large number of closely spaced coronal sections can be stacked appropriately to form a three-dimensional (3D) image. 3D autoradiography allows investigators to observe cerebral sections and surfaces from any viewing angle. A fundamental problem in 3D reconstruction is the alignment (registration) of the coronal sections. A new alignment method based on disparity analysis is presented, which can overcome many of the difficulties encountered by previous methods. The disparity analysis method can deal with asymmetric, damaged, or tilted coronal sections under the same general framework, and it can be used to match coronal sections of different sizes and shapes. Experimental results on alignment and 3D reconstruction are presented.
Collapse
|
|
32 |
51 |
116
|
Zhang WJ, Zou J, Watson LG, Zhao W, Zong GH, Bi SS. The constant-Jacobian method for kinematics of a three-DOF planar micro-motion stage. ACTA ACUST UNITED AC 2002. [DOI: 10.1002/rob.1070] [Citation(s) in RCA: 51] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
|
23 |
51 |
117
|
Zhao W, Wolfender JL, Hostettmann K, Xu R, Qin G. Antifungal alkaloids and limonoid derivatives from Dictamnus dasycarpus. PHYTOCHEMISTRY 1998; 47:7-11. [PMID: 9429316 DOI: 10.1016/s0031-9422(97)00541-4] [Citation(s) in RCA: 51] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/11/2023]
Abstract
From the root bark of Dictamnus dasycarpus (Rutaceae), four limonoid derivatives, two furoquinoline alkaloids, five limonoids, two sesquiterpenes and three steroids were isolated and their structures elucidated on the basis of various spectroscopic methods. Among the identified compounds, one was determined to be a new natural product, 6 beta-hydroxyfraxinellone, while six compounds were found to be active against the plant pathogenic fungus Cladosporium cucumerinum. The relationship between the structures of limonoid derivatives and their inhibitory activity against fungal growth was investigated.
Collapse
|
|
27 |
51 |
118
|
Zhao W, Cavallaro S, Gusev P, Alkon DL. Nonreceptor tyrosine protein kinase pp60c-src in spatial learning: synapse-specific changes in its gene expression, tyrosine phosphorylation, and protein-protein interactions. Proc Natl Acad Sci U S A 2000; 97:8098-103. [PMID: 10884433 PMCID: PMC16676 DOI: 10.1073/pnas.97.14.8098] [Citation(s) in RCA: 51] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
c-src is a nonreceptor tyrosine protein kinase that is highly concentrated in synaptic regions, including synaptic vesicles and growth cones. Here, we report that the mRNA signal of pp60c-src is widely distributed in the rat brain with particularly high concentrations in the hippocampus. After spatial maze learning, up-regulation of c-src mRNA was observed in the CA3 region of the hippocampus, which was accompanied by increases in pp60c-src protein in hippocampal synaptosomal preparations. Training also triggered an increase in c-src protein tyrosine kinase activity that was correlated with its tyrosine dephosphorylation in the synaptic membrane fraction. After training, pp60c-src from hippocampus showed enhanced interactions with synaptic proteins such as synapsin I, synaptophysin, and the type 2 N-methyl-d-aspartate receptor, as well as the cytoskeletal protein actin. The association of pp60c-src with insulin receptor in the synaptic membrane fraction, however, was temporally decreased after training. Furthermore, in vitro results showed that Ca(2+) and protein kinase C might be involved in the regulation of protein-protein interactions of pp60c-src. These results suggest, therefore, that pp60c-src participates in the regulation of hippocampal synaptic activity during learning and memory.
Collapse
|
research-article |
25 |
51 |
119
|
Buskulic D, Casper D, Bonis I, Decamp D, Ghez P, Goy C, Lees JP, Minard MN, Odier P, Pietrzyk B, Ariztizabal F, Comas P, Crespo JM, Efthymiopoulos I, Fernandez E, Fernandez-Bosman M, Gaitan V, Garrido L, Martinez M, Mattison T, Ortreu S, Pacheco A, Padilla C, Pascual A, Creanza D, Palma M, Farilla A, Iaselli G, Maggi G, Marinelli N, Natali S, Nuzzo S, Ranieri A, Raso G, Romano F, Ruggieri F, Selvaggi G, Silvestris L, Tempesta P, Zito G, Chai Y, Huang D, Huang X, Lin J, Wang T, Xie Y, Xu D, Xu R, Zhang J, Zhang L, Zhao W, Bonvicini G, Boudreau J, Drevermann H, Forty RW, Ganis G, Gay C, Girone M, Hagelberg R, Harvey J, Hilgart J, Jacobsen R, Jost B, Knobloch J, Lehraus I, Maggi M, Markou C, Mato P, Meinhard H, Minten A, Miquel R, Palazzi P, Pater JR, Perlas JA, Perrodo P, Pusztaszeri JF, Ranjard F, Rolandi L, Rothberg J, Ruan T, Saich M, Schlatter D, Schmelling M, Sefkow F, Tejessy W, Tomalin IR, Veenhof R, Wachsmuth H, Wasserbaech S, Wiedenmann W, Wildish T, Witzeling W, Wotschack J, Ajaltouni Z, Bardadin-Otwinowska M, Barres A, Boyer C, Falvard A, Gay P, Guicheney C, Henrard P, Jousset J, Michel B, Montret JC, Pallin D, Perret P, Podlyski F, Proriol J, Saadi F, Fearnley T, Hansen JB, Hansen JD, Hansen JR, Hansen PH, Johnson SD, Møllerud R, Nilsson BS, Kyriakis A, Simopoulou E, Siotis I, Vayaki A, Zachariadou K, Badier J, Blondel A, Bonneaud G, Brient JC, Bourdon B, Fouque G, Passalacqua L, Rougé A, Rumpf M, Tanaka R, Verderi M, Videau H, Candlin DJ, Parsons MI, Veitch E, Focardi E, Moneta L, Parrini G, Corden M, Delfino M, Georgiopoulos C, Jaffe DE, Levinthal D, Antonelli A, Bencivenni G, Bologna G, Bossi F, Campana P, Capon G, Cerutti F, Chiarella V, Felici G, Laurelli P, Mannocchi G, Murtas F, Murtas GP, Pepe-Altarelli M, Salomone S, Colrain P, Have I, Knowles IG, Lynch JG, Maitland W, Morton WT, Raine C, Reeves P, Scarr JM, Smith K, Smith MG, Thompson AS, Thorn S, Turnbull RM, Becker U, Braun O, Geweniger C, Hanke P, Hepp V, Kluge EE, Putzer A, Rensch B, Schmidt M, Stenzel H, Tittel K, Wunsch M, Beuselinck R, Binnie DM, Cameron W, Cattaneo M, Colling DJ, Dornan PJ, Hassard JF, Konstantinidis N, Moutoussi A, Nash J, Payne DG, Martin G, Sedgbeer JK, Wright AG, Girtler P, Kuhn D, Rudolph G, Vogl R, Bowdery CK, Brodbeck TJ, Finch AJ, Foster F, Hughes G, Jackson D, Keemer NR, Nuttall M, Patel A, Sloan T, Snow SW, Whelan EP, Galla A, Greene AM, Kleinknecht K, Raab J, Renk B, Sander HG, Schmidt H, Walther SM, Wanke R, Wolf B, Bencheikh AM, Benchouk C, Bonissent A, Calvet D, Carr J, Coyle P, Diaconu C, Etienne F, Nicod D, Payre P, Roos L, Rousseau D, Schwemling P, Talby M, Adlung S, Assmann R, Bauer C, Blum W, Brown D, Cattaneo P, Dehning B, Dietl H, Dydak F, Frank M, Halley AW, Jakobs K, Lauber J, Lütjens G, Lutz G, Männer W, Moser HG, Richter R, Schröder J, Schwarz AS, Settles R, Seywerd H, Stierlin U, Stiegler U, Denis RS, Wolf G, Alemany R, Boucrot J, Callot O, Cordier A, Davier M, Duflot L, Grivaz JF, Heusse P, Janot P, Kim DW, Diberder F, Lefrançois J, Lutz AM, Musolino G, Schune MH, Veillet JJ, Videau I, Abbaneo D, Bagliesi G, Batignani G, Bottigli U, Bozzi C, Calderini G, Carpinelli M, Ciocci MA, Ciulli V, Dell'Orso R, Ferrante I, Fidecaro F, Foa L, Forti F, Giassi A, Giorgi MA, Gregorio A, Ligabue F, Lusiani A, Marrocchesi PS, Martin EB, Messineo A, Palla F, Rizzo G, Sanguinetti G, Spagnolo P, Steinberger J, Tenchini R, Tonelli G, Triggiani G, Valassi A, Vannini C, Venturi A, Verdini PG, Walsh J, Betteridge AP, Gao Y, Green MG, Johnson DL, March PV, Medcalf T, Mir LM, Quazi IS, Strong JA, Bertin V, Botterill DR, Clifft RW, Edgecock TR, Haywood S, Edwards M, Norton PR, Thompson JC, Bloch-Devaux B, Colas P, Duarte H, Emery S, Kozanecki W, Lançon E, Lemaire MC, Locci E, Marx B, Perez P, Rander J, Renardy JF, Rosowsky A, Roussarie A, Schuller JP, Schwindling J, Mohand D, Vallage B, Johnson RP, Litke AM, Taylor G, Wear J, Babbage W, Booth CN, Buttar C, Cartwright S, Combley F, Dawson I, Thompson LF, Böhrer A, Brandt S, Cowan G, Feigl E, Grupen C, Lutters G, Minguet-Rodriguez J, Rivera F, Saraiva P, Schäfer U, Smolik L, Bosisio L, Marina RD, Giannini G, Gobbo B, Pitis L, Ragusa F, Bellantoni L, Chen W, Conway JS, Feng Z, Ferguson DPS, Gao YS, Grahl J, Harton JL, Hayes OJ, Hu H, Nachtman JM, Pan YB, Saadi Y, Schmitt M, Scott I, Sharma V, Turk JD, Walsh AM, Weber FV, Wu SL, Wu X, Yamartino JM, Zheng M, Zobernig G. Heavy flavour production and decay with prompt leptons in the ALEPH detector. ACTA ACUST UNITED AC 1994. [DOI: 10.1007/bf01560237] [Citation(s) in RCA: 50] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
|
31 |
50 |
120
|
Xu X, Wan W, Ji L, Lao S, Powers AS, Zhao W, Erikson JM, Zhang JQ. Exercise training combined with angiotensin II receptor blockade limits post-infarct ventricular remodelling in rats. Cardiovasc Res 2008; 78:523-32. [DOI: 10.1093/cvr/cvn028] [Citation(s) in RCA: 50] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
|
17 |
50 |
121
|
Zhao W, Schorey JS, Groger R, Allen PM, Brown EJ, Ratliff TL. Characterization of the fibronectin binding motif for a unique mycobacterial fibronectin attachment protein, FAP. J Biol Chem 1999; 274:4521-6. [PMID: 9988684 DOI: 10.1074/jbc.274.8.4521] [Citation(s) in RCA: 49] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Studies were performed to define the fibronectin binding motif of the previously identified Mycobacterium avium fibronectin attachment protein (FAP-A). Using synthetic peptides of a previously identified fibronectin binding region (amino acids 269-292), the minimal binding sequence was determined to be 12 amino acids, 269-280 (FAP-A-(269-280)). Synthetic peptides were prepared in which each amino acid in the 269-280 sequence was substituted with Ala. Assessment of the effect of Ala substitution on fibronectin binding showed that the presence of Ala at amino acids 273-276 (RWFV) completely abrogated fibronectin binding activity. Furthermore, the ability to inhibit the attachment of viable Mycobacterium bovis BCG to fibronectin was abrogated by Ala substitution at the RWFV sites. To validate the function of RWFV, further studies were performed with recombinant FAP-A in which single Ala mutations were generated for the RWFV sites and as controls at amino acids 269 and 280. Mutant FAP-A containing single Ala substitutions at the RWFV sites (amino acids 273, 274, 275, or 276) showed significant abrogation of fibronectin binding function. Recombinant FAP-A with Ala substitutions at either 269 or 280 showed wild type activity. When the four essential amino acids (RWFV) were either substituted en bloc with Ala or were all deleted, complete loss of fibronectin binding function was observed. Control recombinant proteins with en bloc Ala substitutions or deletions at four positions outside the fibronectin binding region (amino acids 255-257) retained functional activity. These data show that the RWFV sequence is necessary for fibronectin binding function of FAP-A. Furthermore, the data suggest that mycobacterial FAP proteins, all of which share the RWFV binding motif, constitute a family of highly homologous proteins that bind fibronectin in a unique manner.
Collapse
|
|
26 |
49 |
122
|
Lee SW, Wang HZ, Zhao W, Ney P, Brink PR, Christ GJ. Prostaglandin E1 activates the large-conductance KCa channel in human corporal smooth muscle cells. Int J Impot Res 1999; 11:189-99. [PMID: 10467518 DOI: 10.1038/sj.ijir.3900399] [Citation(s) in RCA: 49] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
The large conductance calcium-sensitive potassium channel (KCa or maxi-K) is an important modulator of human corporal smooth muscle tone, and therefore, erectile capacity. The goal of this investigation was to evaluate the actions of prostaglandin E1 (PGE1), the most widely used and effective drug for the treatment of impotence, on the activity of the KCa channel, a prominent K+ current present in human corporal smooth muscle. Whole-cell patch clamp studies conducted on short-term cultured and enzymatically dissociated human corporal smooth muscle cells, revealed mean resting potentials of -50.8 +/- 2.1 mV (n = 8) and -34 +/- 4 mV (n = 8), respectively. In the attached-patch configuration, the corresponding single-channel slope conductance values for the KCa channel subtype were 173 +/- 4 pS (n = 8) in cultured cells, and 190 +/- 13 pS (n = 3) in freshly isolated myocytes. Furthermore, voltage clamp experiments revealed that relative to control values, the application of PGE1 to cultured cells (3.3 or 33 microM) elicited an apparent increase in both the open probability (Po; ranging from 1.2-23 fold), and the mean open time (5-6 fold) of the KCa channel at membrane potentials of +90 mV and +110 mV. PGE1-induced alterations in KCa channel activity were also observed in freshly isolated corporal myocytes. In the whole cell-recording mode, statistically significant, Charybdotoxin-sensitive (100 nM) 2-3 fold increases in the outward K+ currents were observed in both cultured and freshly isolated corporal myocytes. The presence of a PKA inhibitor (fragment 6-22 amide; 10 microM) in the pipette tip was also associated with a nearly complete ablation of the observed PGE1-induced whole cell K+ currents. Taken together, these data confirm and extend our previous observations, and indicate that PGE1-induced relaxation of human corporal smooth muscle is related, at least in part, to activation of the KCa channel subtype resulting in cellular hyperpolarization.
Collapse
|
|
26 |
49 |
123
|
Zhao W, Devamanoharan PS, Henein M, Ali AH, Varma SD. Diabetes-induced biochemical changes in rat lens: attenuation of cataractogenesis by pyruvate. Diabetes Obes Metab 2000; 2:165-74. [PMID: 11220552 DOI: 10.1046/j.1463-1326.2000.00079.x] [Citation(s) in RCA: 49] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
AIM Studies have been conducted to determine the effect of pyruvate administration on the biochemistry of rat lens and the status of its transparency as affected by diabetic conditions. METHODS Sprague-Dawley rats were rendered diabetic by intravenous (i.v.) injection of streptozotocin (55 mg/kg body weight (b.w.)) and treated with sodium pyruvate (2%) in drinking water. The levels of glucose, fructose, sorbitol, ATP, GSH, MDA as well as glycated proteins in the lenses were determined at various intervals after the onset of diabetes and the values compared with untreated diabetic controls. The progress of cataract formation and associated histological changes in the tissue were also monitored. RESULTS Studies show that the pyruvate treatment decreased the extent of several biochemical changes known to be associated with cataract formation, such as the elevation in the levels of glycated proteins, sorbitol, lipid peroxidation (MDA) and inhibition of the cation pump. The progress of cataract was also significantly delayed. CONCLUSION Exogenous administration of this compound hence was found to exert an overall protective effect against cataract formation induced by the diabetic conditions.
Collapse
|
|
25 |
49 |
124
|
Zhao W, Kridel S, Thorburn A, Kooshki M, Little J, Hebbar S, Robbins M. Fatty acid synthase: a novel target for antiglioma therapy. Br J Cancer 2006; 95:869-78. [PMID: 16969344 PMCID: PMC2360524 DOI: 10.1038/sj.bjc.6603350] [Citation(s) in RCA: 48] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
Abstract
High levels of fatty acid synthase (FAS) expression have been observed in several cancers, including breast, prostate, colon and lung carcinoma, compared with their respective normal tissue. We present data that show high levels of FAS protein in human and rat glioma cell lines and human glioma tissue samples, as compared to normal rat astrocytes and normal human brain. Incubating glioma cells with the FAS inhibitor cerulenin decreased endogenous fatty acid synthesis by approximately 50%. Cell cycle analysis demonstrated a time- and dose-dependent increase in S-phase cell arrest following cerulenin treatment for 24 h. Further, treatment with cerulenin resulted in time- and dose-dependent decreases in glioma cell viability, as well as reduced clonogenic survival. Increased apoptotic cell death and PARP cleavage were observed in U251 and SNB-19 cells treated with cerulenin, which was independent of the death receptor pathway. Overexpressing Bcl-2 inhibited cerulenin-mediated cell death. In contrast, primary rat astrocytes appeared unaffected. Finally, RNAi-mediated knockdown of FAS leading to reduced FAS enzymatic activity was associated with decreased glioma cell viability. These findings suggest that FAS might be a novel target for antiglioma therapy.
Collapse
|
Research Support, N.I.H., Extramural |
19 |
48 |
125
|
Zhao W, Neufeld DA. Bone regrowth in young mice stimulated by nail organ. THE JOURNAL OF EXPERIMENTAL ZOOLOGY 1995; 271:155-9. [PMID: 7884389 DOI: 10.1002/jez.1402710212] [Citation(s) in RCA: 48] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
Recent studies of postamputational repair following digit-tip amputation revealed an unexpected correlation between nail regrowth and bone regrowth in mice. To examine putative effects of nail on bone regrowth, phalangeal tips were amputated such that nail was artificially removed from distal levels or retained following proximal level amputations. In the absence of nail, bone did not regrow at distal levels. Conversely, when nail was surgically retained bone regrew from proximal levels. The nail organ profoundly influences bone regrowth.
Collapse
|
Comparative Study |
30 |
48 |